Physician
Starling Physicians, PLLC
Starling Physicians, PLLC was paid $38.11M by Medicaid between Jan 2018 and Dec 2024, across 269 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 20% of everything it billed.
33Billing provider infoSTARLING PHYSICIANS, PLLC
ROCKY HILL, CT 06067
ROCKY HILL, CT 06067
33aNPI1467537290assigned 10/27/2006
33bProvider typeAllergy Physician
28Total paid$38.11M
24GClaims1,352,834
24DCodes billed269
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Allergy Physician providers in Connecticut
Rank by total paid#1 of 5
Median peer was paid$92K
This provider vs. median415×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 182,234 | $5.56M | |
| 2019 | 162,960 | $5.56M | |
| 2020 | 133,043 | $4.57M | |
| 2021 | 156,894 | $5.70M | |
| 2022 | 156,683 | $6.44M | |
| 2023 | 370,012 | $5.37M | |
| 2024incomplete | 191,008 | $4.90M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 162,713 | 124,641 | $7.60M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 170,550 | 135,076 | $6.38M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 6.9% | 139,470 | 38,193 | $2.62M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.0% | 51,237 | 43,846 | $1.90M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.9% | 17,356 | 14,563 | $1.87M |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 4.3% | 13,026 | 11,635 | $1.64M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.3% | 15,753 | 13,632 | $1.63M |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | 4.2% | 23,509 | 18,850 | $1.59M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.5% | 14,141 | 11,201 | $1.34M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.8% | 9,990 | 8,457 | $1.08M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 2.8% | 15,124 | 6,842 | $1.06M |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 2.5% | 8,935 | 6,829 | $951K |
257 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 1.9% | 9,466 | $716K |
| 99222 | Initial hospital care, per day, moderate complexity | 1.5% | 17,627 | $560K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | 1.0% | 16,538 | $383K |
| 96127 | <1% | 23,394 | $371K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 11,845 | $296K |
| J0178 | Injection, aflibercept, 1 mg | <1% | 656 | $274K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 8,444 | $273K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 5,740 | $267K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 7,485 | $256K |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 6,718 | $253K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 11,454 | $236K |
| 99223 | Prolong inpt eval add15 m | <1% | 4,496 | $210K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 13,647 | $206K |
| 36902 | <1% | 1,276 | $176K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 7,788 | $172K |
| 99173 | <1% | 25,999 | $163K | |
| 99205 | Prolong outpt/office vis | <1% | 1,432 | $158K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 2,977 | $144K |
| 93000 | <1% | 29,753 | $143K | |
| 92551 | <1% | 25,883 | $142K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 5,574 | $137K |
| 99174 | <1% | 7,987 | $131K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 5,097 | $129K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 2,795 | $127K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 9,222 | $109K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 3,694 | $107K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 5,465 | $98K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 5,746 | $97K |
| 90961 | <1% | 1,274 | $96K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 2,301 | $90K |
| 99307 | <1% | 5,523 | $88K | |
| 96161 | <1% | 5,941 | $87K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 1,257 | $83K |
| 99305 | <1% | 1,924 | $75K | |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 6,902 | $73K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 12,704 | $67K |
| 92015 | Determination of refractive state | <1% | 4,463 | $66K |
| 99188 | <1% | 3,397 | $63K | |
| 92134 | <1% | 7,919 | $63K | |
| 95117 | <1% | 6,891 | $59K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,064 | $54K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 18,086 | $54K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 653 | $49K |
| 99306 | Prolong nursin fac eval 15m | <1% | 759 | $47K |
| 99070 | <1% | 3,944 | $38K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 253 | $38K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,740 | $37K |
| 81002 | <1% | 24,057 | $34K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,325 | $32K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,451 | $30K |
| 0001A | <1% | 733 | $27K | |
| 0002A | <1% | 714 | $27K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 926 | $27K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 274 | $25K |
| 0071A | <1% | 730 | $25K | |
| J1439 | Injection, ferric carboxymaltose, 1 mg | <1% | 43 | $25K |
| 80305 | <1% | 4,777 | $24K | |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | <1% | 213 | $24K |
| 92250 | <1% | 1,399 | $23K | |
| 20610 | <1% | 1,212 | $21K | |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | <1% | 391 | $21K |
| 64483 | <1% | 241 | $19K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,959 | $18K |
| 90686 | <1% | 23,151 | $17K | |
| 17110 | <1% | 858 | $17K | |
| 99442 | <1% | 605 | $15K | |
| 92083 | <1% | 1,086 | $15K | |
| 99152 | <1% | 1,879 | $15K | |
| 93015 | <1% | 578 | $15K | |
| 82570 | <1% | 7,958 | $15K | |
| 76830 | Ultrasound, transvaginal | <1% | 343 | $14K |
| 73630 | <1% | 1,629 | $13K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,071 | $13K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 406 | $13K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,391 | $13K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 191 | $12K |
| 94664 | <1% | 1,517 | $12K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 377 | $12K |
| 31231 | <1% | 978 | $11K | |
| 99318 | <1% | 306 | $11K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 5,669 | $10K |
| 73562 | <1% | 1,498 | $9K | |
| 0072A | <1% | 240 | $9K | |
| 59025 | Fetal non-stress test | <1% | 214 | $9K |
| 99385 | <1% | 166 | $9K | |
| 11721 | <1% | 2,266 | $8K | |
| 92285 | <1% | 629 | $8K | |
| 73560 | <1% | 1,218 | $7K | |
| 94010 | <1% | 984 | $7K | |
| 99245 | <1% | 58 | $7K | |
| 96160 | <1% | 541 | $7K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,230 | $7K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 293 | $7K |
| 11102 | <1% | 297 | $6K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,511 | $6K |
| 99381 | <1% | 86 | $6K | |
| 87631 | <1% | 47 | $6K | |
| 99217 | <1% | 241 | $6K | |
| 99292 | <1% | 137 | $5K | |
| 99401 | <1% | 120 | $5K | |
| 36416 | <1% | 1,732 | $5K | |
| 51798 | <1% | 1,552 | $4K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 114 | $4K |
| 69210 | <1% | 1,143 | $4K | |
| 99254 | <1% | 104 | $4K | |
| 36901 | <1% | 35 | $3K | |
| 11100 | <1% | 154 | $3K | |
| 0011A | <1% | 194 | $3K | |
| 0051A | <1% | 117 | $3K | |
| 0081A | <1% | 83 | $3K | |
| 0012A | <1% | 145 | $3K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 113 | $3K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,976 | $3K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 69 | $3K |
| 99497 | <1% | 159 | $3K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 865 | $3K |
| 20611 | <1% | 111 | $3K | |
| 94729 | <1% | 271 | $2K | |
| 81003 | <1% | 7,297 | $2K | |
| 62323 | <1% | 47 | $2K | |
| 73130 | <1% | 245 | $2K | |
| 99443 | <1% | 68 | $2K | |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 165 | $2K |
| 83861 | <1% | 437 | $2K | |
| 96367 | <1% | 190 | $2K | |
| 73030 | <1% | 260 | $2K | |
| 76801 | <1% | 40 | $2K | |
| 72110 | <1% | 112 | $2K | |
| 95251 | <1% | 309 | $2K | |
| 87070 | <1% | 347 | $2K | |
| 81025 | <1% | 397 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 196 | $2K |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 2,061 | $2K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 30 | $2K |
| 94060 | <1% | 147 | $2K | |
| 92235 | <1% | 39 | $1K | |
| 90937 | <1% | 19 | $1K | |
| 64493 | <1% | 26 | $1K | |
| 93296 | <1% | 262 | $1K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 21 | $1K |
| 92557 | <1% | 566 | $1K | |
| 99243 | <1% | 15 | $1K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 447 | $1K |
| 99051 | <1% | 168 | $1K | |
| 99225 | <1% | 46 | $1K | |
| 93922 | <1% | 32 | $1K | |
| 99490 | Ccm add 20min | <1% | 113 | $1K |
| 20552 | <1% | 97 | $997.07 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 232 | $952.21 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 459 | $936.77 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 381 | $934.43 |
| 99441 | <1% | 186 | $839.65 | |
| 94760 | <1% | 1,421 | $810.72 | |
| 90480 | <1% | 21 | $800.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,190 | $780.00 |
| 0031A | <1% | 38 | $760.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 23 | $742.96 |
| 31575 | <1% | 118 | $706.87 | |
| 0003A | <1% | 17 | $680.00 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 12 | $673.60 |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 14 | $668.21 |
| 81001 | <1% | 589 | $659.53 | |
| 99397 | <1% | 165 | $629.91 | |
| 94726 | <1% | 65 | $608.36 | |
| 0013A | <1% | 16 | $600.00 | |
| 76770 | <1% | 16 | $547.05 | |
| L1820 | Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 13 | $515.43 |
| 82274 | <1% | 37 | $498.96 | |
| 92587 | <1% | 20 | $480.88 | |
| 95886 | <1% | 13 | $447.48 | |
| 52000 | <1% | 29 | $405.00 | |
| 93294 | <1% | 88 | $390.04 | |
| 94727 | <1% | 73 | $345.15 | |
| D1206 | Topical application of fluoride varnish | <1% | 14 | $280.00 |
| 92133 | <1% | 110 | $277.13 | |
| 92567 | <1% | 474 | $249.88 | |
| 90671 | <1% | 2,814 | $246.90 | |
| 72100 | <1% | 30 | $246.40 | |
| 85018 | <1% | 2,451 | $240.44 | |
| 90651 | <1% | 2,195 | $238.00 | |
| 92002 | <1% | 18 | $237.86 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 65 | $233.01 |
| 73610 | <1% | 14 | $215.05 | |
| 73564 | <1% | 20 | $183.40 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 42 | $182.40 |
| 92020 | <1% | 26 | $178.13 | |
| 90656 | <1% | 1,756 | $134.10 | |
| 87210 | <1% | 37 | $133.87 | |
| 90734 | <1% | 1,332 | $121.56 | |
| 73620 | <1% | 15 | $121.53 | |
| 90662 | <1% | 119 | $86.95 | |
| 82270 | <1% | 33 | $83.97 | |
| 83037 | <1% | 13 | $83.75 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 13 | $78.50 |
| 95012 | <1% | 13 | $78.47 | |
| 90461 | <1% | 21,747 | $70.00 | |
| 95115 | <1% | 26 | $66.84 | |
| 94618 | <1% | 12 | $64.53 | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 26 | $64.11 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 232 | $60.02 |
| 97161 | <1% | 13 | $50.49 | |
| 83986 | <1% | 13 | $33.88 | |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | <1% | 12 | $33.57 |
| J3490 | Unclassified drugs | <1% | 60 | $30.37 |
| 17000 | <1% | 12 | $22.05 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 151 | $18.08 |
| 99072 | <1% | 1,462 | $15.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 96 | $2.84 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 101 | $2.53 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 30 | $0.29 |
| 90670 | <1% | 6,053 | $0.02 | |
| 90648 | 0% | 4,571 | $0.00 | |
| 1160F | 0% | 42,975 | $0.00 | |
| 90633 | 0% | 1,436 | $0.00 | |
| 1159F | 0% | 43,252 | $0.00 | |
| 3078F | 0% | 1,821 | $0.00 | |
| 90685 | 0% | 972 | $0.00 | |
| 91300 | 0% | 1,546 | $0.00 | |
| 88312 | 0% | 60 | $0.00 | |
| 90621 | 0% | 226 | $0.00 | |
| 0502F | 0% | 1,155 | $0.00 | |
| 90715 | 0% | 181 | $0.00 | |
| 3077F | 0% | 526 | $0.00 | |
| 90710 | 0% | 25 | $0.00 | |
| 91308 | 0% | 83 | $0.00 | |
| 90700 | 0% | 25 | $0.00 | |
| 90707 | 0% | 12 | $0.00 | |
| 91322 | 0% | 16 | $0.00 | |
| 90680 | 0% | 4,191 | $0.00 | |
| 3008F | 0% | 29,478 | $0.00 | |
| 90723 | 0% | 2,600 | $0.00 | |
| 3075F | 0% | 829 | $0.00 | |
| 90697 | 0% | 1,956 | $0.00 | |
| 1126F | 0% | 9,091 | $0.00 | |
| 3079F | 0% | 934 | $0.00 | |
| 1170F | 0% | 5,953 | $0.00 | |
| 91305 | 0% | 123 | $0.00 | |
| 1125F | 0% | 3,728 | $0.00 | |
| 3044F | 0% | 1,295 | $0.00 | |
| 99000 | 0% | 1,694 | $0.00 | |
| 91301 | 0% | 372 | $0.00 | |
| 3074F | 0% | 937 | $0.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 626 | $0.00 |
| 91307 | 0% | 1,026 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 408 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 146 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 130 | $0.00 |
| 90647 | 0% | 27 | $0.00 | |
| 90716 | 0% | 24 | $0.00 | |
| 88304 | 0% | 26 | $0.00 | |
| 1157F | 0% | 15 | $0.00 | |
| 94761 | 0% | 23 | $0.00 | |
| 90620 | 0% | 14 | $0.00 | |
| 90381 | 0% | 13 | $0.00 | |
| 90677 | 0% | 13 | $0.00 | |
| 91303 | 0% | 34 | $0.00 | |
| 90696 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEBENGER, JEFFREY (CEO)
| Provider | Location | Paid |
|---|---|---|
| Starling Physicians, PLLC | New Britain, CT | $4.36M |
| Summit Medical Group PA | Woodland Park, NJ | $45K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.